(Q45878050)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378018%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378018%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Sajani S Lakka

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378018%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Dzung H Dinh

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378018%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

William C Olivero

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378018%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Meena Gujrati

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378018%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

language of work or name

English

0 references

publication date

1 November 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378018%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378018%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378018%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378018%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

8486-8496

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378018%20AND%20SRC:MED&resulttype=core&format=json

Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo.

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

Time and dose dependency of the suppression of pulmonary metastases of rat mammary cancer by amiloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

Inhibition of in vivo tumorigenicity and invasiveness of a human glioblastoma cell line transfected with antisense uPAR vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

Epidermal growth factor receptor-dependent and -independent cell-signaling pathways originating from the urokinase receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

Matrix Metalloproteinase Stromelysin-1 Triggers a Cascade of Molecular Alterations That Leads to Stable Epithelial-to-Mesenchymal Conversion and a Premalignant Phenotype in Mammary Epithelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

The urokinase/urokinase receptor system in retinal neovascularization: inhibition by A6 suggests a new therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

Immunolocalization of cathepsin B in human glioma: implications for tumor invasion and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

The role of plasminogen activators in the regulation of connective tissue metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

Binding of Urokinase-type Plasminogen Activator to Its Receptor in MCF-7 Cells Activates Extracellular Signal-regulated Kinase 1 and 2 Which Is Required for Increased Cellular Motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

Overexpression and localization of cathepsin B during the progression of human gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

Targeting urokinase-type plasminogen activator receptor on human glioblastoma tumors with diphtheria toxin fusion protein DTAT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

RNA interference: listening to the sound of silence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

Biological Activation of pro-HGF (Hepatocyte Growth Factor) by Urokinase Is Controlled by a Stoichiometric Reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

7 January 2021

Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

7 January 2021

The urokinase-type plasminogen activator system in cancer metastasis: A review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

7 January 2021

Invasiveness of transformed human breast epithelial cell lines is related to cathepsin B and inhibited by cysteine proteinase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

7 January 2021

Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin C.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

7 January 2021

Participation of intracellular cysteine proteinases, in particular cathepsin B, in degradation of collagen in periosteal tissue explants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

7 January 2021

Cathepsin B knockout mice are resistant to tumor necrosis factor-alpha-mediated hepatocyte apoptosis and liver injury: implications for therapeutic applications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

7 January 2021

Comparative localization of cathepsin B protein and activity in colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

7 January 2021

Complex roles of tissue inhibitors of metalloproteinases in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

7 January 2021

Tumor progression and angiogenesis: cathepsin B & Co.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

7 January 2021

The urokinase plasminogen activator receptor in the regulation of the actin cytoskeleton and cell motility

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

7 January 2021

Increased cell-surface urokinase in advanced ovarian cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

7 January 2021

Modulation of cystatin C expression impairs the invasive and tumorigenic potential of human glioblastoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

7 January 2021

Stimulation of angiogenesis through cathepsin B inactivation of the tissue inhibitors of matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

7 January 2021

Adenovirus-mediated delivery of a uPA/uPAR antagonist suppresses angiogenesis-dependent tumor growth and dissemination in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

7 January 2021

RNA interference in adult mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

7 January 2021

Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

7 January 2021

In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

7 January 2021

Abrogation of the invasion of human bladder tumor cells by using protease inhibitor(s).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

7 January 2021

High-affinity urokinase-derived cyclic peptides inhibiting urokinase/urokinase receptor-interaction: effects on tumor growth and spread

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

7 January 2021

Tumor-associated urokinase-type plasminogen activator: biological and clinical significance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

7 January 2021

Immunohistochemical localization of cathepsin B in neoplastic human prostate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

7 January 2021

RNA interference targeting Fas protects mice from fulminant hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

7 January 2021

Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

7 January 2021

siRNA-mediated gene silencing in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207879

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1207879

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378018%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

1 January 2020

1042963434

0 references

Fatcat ID

release_xl3brwd4gvbwtpchdtwlbljwa4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xl3brwd4gvbwtpchdtwlbljwa4

24 November 2022

mapped directly with Wikidata item

1 reference